Neuroprotection in Parkinson's Disease; a Commentary

By Gatto Emilia Mabel   Riobó Natalia   Carreras MarÍa Cecilia   Poderoso Juan José   Micheli Federico E.  

Neurotoxicity Research, Vol. 4, Iss. 2, 2002-01 ,pp. : 141-145

Springer Publishing Company

Access to resources Recommend Favorite

Parkinson's disease, insulin resistance and novel agents of neuroprotection

By Aviles-Olmos Iciar  

Brain, Vol. 136, Iss. 2, 2013-02 ,pp. : 374-384

Oxford University Press

Access to resources Recommend Favorite

Gene Therapeutic Strategies for Neuroprotection: Implications for Parkinson's Disease

By Bowers W.J.   Howard D.F.   Federoff H.J.  

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 58-68

Elsevier

Access to resources Recommend Favorite

Neuroprotection of Pramipexole in UPS Impairment Induced Animal Model of Parkinson’s Disease

By Li Chao   Guo Yuan   Xie Wenjie   Li Xingang   Janokovic Joseph   Le Weidong  

Neurochemical Research, Vol. 35, Iss. 10, 2010-10 ,pp. : 1546-1556

Springer Publishing Company

Access to resources Recommend Favorite

Defining premotor Parkinson's disease: a window of opportunity for neuroprotection?

By Mahlknecht Philipp   Poewe Werner  

Neurodegenerative Disease Management, Vol. 3, Iss. 1, 2013-02 ,pp. : 61-70

Future Medicine

Access to resources Recommend Favorite